The CureDM product pipeline includes novel peptides and a formulation that targets the hepatic portal system for improved efficacy. Each compound is based on the application of proteomics to known physiologic mechanisms to develop innovative new treatments for diabetes and related metabolic disorders.

Learn More

CDM1101
CDM1102
CDM1103